Moderna finalizes agreement with the government of the republic of kenya to establish an mrna manufacturing facility

Facility to enable access to manufactured mrna vaccines for kenya and the african continent, providing health security and building upon moderna's global public health commitments the facility will be capable of producing up to 500 million doses each year cambridge, ma & nairobi, kenya / accesswire / march 30, 2023 / moderna, inc. (nasdaq:mrna), a biotechnology company pioneering messenger rna (mrna) therapeutics and vaccines, and the government of the republic of kenya have finalized an agreement to establish an mrna manufacturing facility in the republic of kenya. this will be the company's first mrna manufacturing facility in africa.
MRNA Ratings Summary
MRNA Quant Ranking